| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 14,173 | $6.64 | $94,163.95 | +0.8% | -14.9% | -76.1% | |
| Mar 14, 2023 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 18,800 | $23.70 | $445,530.21 | -0.5% | +6.9% | -47.3% | |
| Mar 14, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $77.61 | $1,542,513.00 | -12.3% | +9.4% | +18.8% | |
| Mar 13, 2023 | XAIR Beyond Air, Inc. | Avniel Amir63 | Chief Business Officer | Buy | 1,000 | $6.40 | $6,400.00 | +0.2% | -9.3% | -74.4% | |
| Mar 13, 2023 | PODD Insulet Corp | Alpuche Charles64 | Advisor | Sell | 23,401 | $305.15 | $7,140,815.15 | -33.9% | -6.4% | -40.1% | |
| Mar 13, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | President, CEO And Chairman | Sell | 10,000 | $37.81 | $378,117.00 | -1.7% | +26.1% | +16.4% | |
| Mar 13, 2023 | PETV Petvivo Holdings, Inc. | Jasper Joseph William | Director | Buy | 2,000 | $3.10 | $6,200.00 | New | - | - | |
| Mar 13, 2023 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 136,520 | $2.97 | $405,464.40 | +4.7% | -18.2% | +47.6% | |
| Mar 13, 2023 | ATEC Alphatec Holdings, Inc. | Pelizzon David R56 | Director, 10% Owner | Buy | 3,100 | $15.24 | $47,244.00 | +1.1% | +1.8% | -11.5% | |
| Mar 13, 2023 | CNMD Conmed Corp | Garner Todd W67 | Executive Vice President &CFO | Sell | 30,000 | $90.93 | $2,727,939.43 | -33.3% | +44.2% | -6.0% | |
| Mar 13, 2023 | CERS Cerus Corp | Jayaraman Vivek K67 | Chief Operating Officer | Sell | 25,356 | $2.80 | $70,996.80 | -1.9% | -13.0% | -26.7% | |
| Mar 13, 2023 | CERS Cerus Corp | Menard Chrystal71 | Chief Legal Officer | Sell | 15,468 | $2.80 | $43,310.40 | -2.2% | -13.0% | -26.7% | |
| Mar 13, 2023 | CERS Cerus Corp | Green Kevin Dennis71 | Chief Financial Officer | Sell | 17,163 | $2.80 | $48,056.40 | -2.0% | -13.0% | -26.7% | |
| Mar 13, 2023 | CERS Cerus Corp | Benjamin Richard J71 | Chief Medical Officer | Sell | 25,353 | $2.79 | $70,781.40 | -2.4% | -13.0% | -26.7% | |
| Mar 13, 2023 | CERS Cerus Corp | Greenman William Mariner70 | President And CEO | Sell | 60,480 | $2.80 | $169,344.00 | -1.1% | -13.0% | -26.7% | |
| Mar 13, 2023 | CERS Cerus Corp | Corash Laurence M73 | Chief Scientific Officer | Sell | 15,342 | $2.80 | $42,957.60 | -0.3% | -13.0% | -26.7% | |
| Mar 13, 2023 | CERS Cerus Corp | Moore Carol78 | SVP Reg. &Quality | Sell | 13,078 | $2.80 | $36,618.40 | -1.6% | -13.0% | -26.7% | |
| Mar 13, 2023 | DXCM Dexcom Inc | Regan Barry J.60 | EVP Operations | Sell | 2,010 | $106.27 | $213,602.70 | -2.8% | +14.7% | +22.3% | |
| Mar 13, 2023 | DXCM Dexcom Inc | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 6,229 | $106.27 | $661,955.83 | -14.8% | +14.7% | +22.3% | |
| Mar 13, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 59,100 | $2.36 | $139,366.35 | +8.2% | -9.7% | -85.9% | |
| Mar 13, 2023 | DXCM Dexcom Inc | Flynn Paul R47 | EVP Global Revenue | Sell | 2,782 | $106.27 | $295,643.14 | -4.8% | +14.7% | +22.3% | |
| Mar 13, 2023 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 14,251 | $10.95 | $156,057.91 | -4.0% | +8.7% | +6.4% | |
| Mar 13, 2023 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 140,000 | $15.17 | $2,123,200.00 | -0.8% | +1.8% | -11.5% | |
| Mar 10, 2023 | OFIX Orthofix Medical Inc. | Maniar Shweta62 | Director | Sell | 4,262 | $17.75 | $75,650.50 | -17.5% | +12.6% | -20.6% | |
| Mar 10, 2023 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 6,517 | $11.04 | $71,947.68 | -98.4% | +8.7% | +10.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.